Status:
UNKNOWN
The Cardioprotective Effects of Adding Ozone To Cardioplegic Solution in Adult Cardiac Surgery
Lead Sponsor:
Assiut University
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
40-70 years
Phase:
PHASE2
PHASE3
Brief Summary
forty patients with age ranged between 40-70 years undergoing elective coronary artery bypass graft surgery with cardiopulmonary bypass will be included, they will divided into two groups. Ozone Grou...
Detailed Description
Ozone Administration Protocol Our procedures for O3T application in CBP surgery conform to international guidelines of the ''Madrid Declaration on Ozone Therapy'' 32 . M-O3T will be carried out as fo...
Eligibility Criteria
Inclusion
- patients undergoing elective CABG surgery
Exclusion
- • left ventricular ejection fraction\< 40%
- diabetic or other metabolic disorders,
- use of left ventricular assist devices,
- Renal failure or on hemodialysis
- Hepatic dysfunction
- Hypothyroidism
- implanted pacemaker
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03876067
Start Date
April 1 2019
End Date
December 1 2022
Last Update
March 19 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.